[go: up one dir, main page]

AR098129A1 - Preparación y administración de soluciones de liberación sostenida de óxido nítrico - Google Patents

Preparación y administración de soluciones de liberación sostenida de óxido nítrico

Info

Publication number
AR098129A1
AR098129A1 ARP140103939A ARP140103939A AR098129A1 AR 098129 A1 AR098129 A1 AR 098129A1 AR P140103939 A ARP140103939 A AR P140103939A AR P140103939 A ARP140103939 A AR P140103939A AR 098129 A1 AR098129 A1 AR 098129A1
Authority
AR
Argentina
Prior art keywords
nitric oxide
administration
preparation
sustained release
release solutions
Prior art date
Application number
ARP140103939A
Other languages
English (en)
Inventor
C Miller Christopher
Han Steve
Stenzler Alex
Regev-Shoshani Gilly
Original Assignee
Bovicor Pharmatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bovicor Pharmatech Inc filed Critical Bovicor Pharmatech Inc
Publication of AR098129A1 publication Critical patent/AR098129A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/30—Gas therapy for therapeutic treatment of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sistema y método de tratamiento de un sujeto con gas de óxido nítrico y/o con soluciones que liberan óxido nítrico. Composiciones y dispositivos útiles para el tratamiento de un sujeto con gas de óxido nítrico y/o soluciones que liberan óxido nítrico.
ARP140103939A 2013-10-18 2014-10-20 Preparación y administración de soluciones de liberación sostenida de óxido nítrico AR098129A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361892681P 2013-10-18 2013-10-18

Publications (1)

Publication Number Publication Date
AR098129A1 true AR098129A1 (es) 2016-05-04

Family

ID=52828763

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140103939A AR098129A1 (es) 2013-10-18 2014-10-20 Preparación y administración de soluciones de liberación sostenida de óxido nítrico

Country Status (6)

Country Link
US (1) US20150157657A1 (es)
EP (1) EP3057645A4 (es)
AR (1) AR098129A1 (es)
AU (1) AU2014337031A1 (es)
CA (1) CA2930189A1 (es)
WO (1) WO2015058127A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2946828A1 (en) * 2014-03-14 2015-09-17 Nitric Solutions, Inc. Treating diseases using nitric oxide releasing solutions
EP3487568B1 (en) 2016-07-20 2021-08-18 Elanco US Inc. Animal intranasal administration device and systems
EP3318532B1 (de) * 2016-11-02 2025-06-25 BSN medical GmbH Verfahren und einrichtung zur no instillation
WO2018160338A1 (en) * 2017-02-28 2018-09-07 Praxair Technology, Inc. System for dispensing a solution of nitric oxide in deionized and/or deoxygenated water from a vessel
US11472705B2 (en) 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
WO2020074957A1 (en) * 2018-10-12 2020-04-16 Sanotize Research And Development Corp. Gas-evolving compositions and container and delivery systems
WO2022013614A1 (en) * 2020-07-16 2022-01-20 Sanotize Research And Development Corp. Methods of treating conditions responsive to nitric oxide therapy
US20230390508A1 (en) * 2021-07-22 2023-12-07 Noxy Health Products, Inc. Nitric oxide nasal delivery apparatus and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
AU2002336401A1 (en) * 2001-09-05 2003-03-18 Cyterra Corporation Nitric oxide generation
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
DK2467173T3 (da) * 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
DK3421042T3 (da) * 2012-03-07 2024-07-22 Beyond Air Ltd Indånding af nitrogenoxid til behandling af luftvejssygdomme

Also Published As

Publication number Publication date
EP3057645A1 (en) 2016-08-24
EP3057645A4 (en) 2017-06-14
US20150157657A1 (en) 2015-06-11
CA2930189A1 (en) 2015-04-23
AU2014337031A1 (en) 2016-06-02
WO2015058127A1 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
AR098129A1 (es) Preparación y administración de soluciones de liberación sostenida de óxido nítrico
EP2988811A4 (en) VENTILATION DEVICES AND CORRESPONDING SYSTEMS AND METHOD
MX2016002137A (es) Ciertas entidades quimicas, composiciones y metodos.
IL243821A0 (en) Systems and methods for the safe transport of medicines
PL3160565T3 (pl) Urządzenia i systemy do dopłucnego dostarczania środków aktywnych
PL3160554T3 (pl) Urządzenia i systemy do dopłucnego dostarczania środków aktywnych
EP2953538A4 (en) OXYGEN MASK AND CONSTITUENT SYSTEM
PT3491948T (pt) Sistemas e métodos de dispositivo de vaporização
BR112015026896A2 (pt) métodos, dispositivos e sistemas para transporte seguro de materiais
EP2968757A4 (en) DEVICES, SYSTEMS AND METHOD FOR THE TRANSDERMAL ADMINISTRATION OF CONNECTIONS
PT3036247T (pt) Método e sistema para tratar lenhina
DK3332773T3 (da) Stabiliseret modified release-vitamin d-formulering og fremgangsmåde til administration heraf
MX2015016627A (es) Vacuna para la malaria.
BR112015019099A2 (pt) Método implementado por computador para gerar uma pilha de chamadas assíncronas e sistema de computador
CL2015002180A1 (es) Terapia de combinación para el tratamiento de neumonía nosocomial
CL2016000392A1 (es) Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune
PH12013000326B1 (en) Method of forming an esd device and structure therefor
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
BR112015016577A2 (pt) elemento de fixação e seringa
BR112016010939A2 (pt) sistema de ignição e método para operação de um sistema de ignição
BR112015028314A2 (pt) Prevenção do risco de narcolepsia em vacinas para gripe
EP3129092A4 (en) Systems and methods for high concentration nitric oxide delivery
KR20180084632A (ko) 섭취에 적합한 디바이스 및 연관된 시스템
CL2016000396A1 (es) Tratamiento contra el mieloma múltiple

Legal Events

Date Code Title Description
FB Suspension of granting procedure